This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Abbott, N J Articles by Dolman, D E. Search for Related Content PubMed PubMed Citation Articles by Abbott, N J Articles by Dolman, D E. Social Bookmarking                         What's this?

The blood-brain barrier in systemic lupus erythematosus

Centre for Neuroscience Research, King’s College London, Guy’s Campus, London SE1 1UL, UK, joan.abbott{at}kcl.ac.uk

L LF Mendonça

Centre for Neuroscience Research, King’s College London, Guy’s Campus, London SE1 1UL, UK, Discipline of Rheumatology, Faculty of Medicine, University of Sao Paulo, Sao Paulo, Brazil

D EM Dolman

Centre for Neuroscience Research, King’s College London, Guy’s Campus, London SE1 1UL, UK

Central nervous system (CNS) involvement may occur in 20-70% of systemic lupus erythematosus (SLE) patients where neurological symptoms are overt; this is termed neuropsychiatric lupus or NPSLE. This review summarizes evidence that damage to the brain endothelium forming the blood-brain barrier (BBB) is a contributoryfactor in NPSLE. The normal CNS is protected by blood-tissue barriers at three sites, the brain endothelium (BBB), the choroid plexus epithelium (blood-CSF barrier) and the arachnoid epithelium. The tight junctions of the barrier layers severely restrict entry of plasma constituentsincluding proteins, so that the CSF and brain interstitial fluid contain low levels of protein. Methods for diagnosing BBB damage include imaging (CT, MRI) using contrast agents, and analysing protein content and profiles of CSF. Changes in the albumin quotient Qalbumin show evidence for barrier damage, while changes in the immunoglobulin (Ig) index can indicate intrathecal antibody production. However, BBB damage may be transient, and hence undetected or underestimated. Few mechanistic studies exist, but the two main candidate mechanisms for BBB damage are microthrombi in cerebral vessels leading to ischaemia, and immune-mediated attack and activation of the endothelium leading to local cytokine production. Both can result in barrier breakdown. Neurological syndromes could then be secondary to damage to the BBB. The implications for treatment of NPSLE are discussed.

Key Words: blood-brain barrier • CNS • SLE

Lupus, Vol. 12, No. 12, 908-915 (2003)
DOI: 10.1191/0961203303lu501oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				O. Kano, K. Arasaki, K. Ikeda, J. Aoyagi, H. Shiraishi, M. Motomura, and Y. Iwasaki Limbic encephalitis associated with systemic lupus erythematosus Lupus, December 1, 2009; 18(14): 1316 - 1319. [Abstract] [PDF]

				S. Matus, P. V. Burgos, M. Bravo-Zehnder, R. Kraft, O. H. Porras, P. Farias, L. F. Barros, F. Torrealba, L. Massardo, S. Jacobelli, et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis J. Exp. Med., December 24, 2007; 204(13): 3221 - 3234. [Abstract] [Full Text] [PDF]

				M.L. Ishimori, B.D. Pressman, D.J. Wallace, and M.H. Weisman Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? Lupus, June 1, 2007; 16(6): 436 - 443. [Abstract] [PDF]

				M. Yin Mok, E. Y T Chan, W. Sing Wong, and C. Sing Lau Intrathecal immunoglobulin production in patients with systemic lupus erythematosus with neuropsychiatric manifestations Ann Rheum Dis, June 1, 2007; 66(6): 846 - 847. [Full Text] [PDF]

				S. Jarius, P. Eichhorn, M. H. Albert, S. Wagenpfeil, M. Wick, B. H. Belohradsky, R. Hohlfeld, D. E. Jenne, and R. Voltz Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNF{alpha}-dependent and Fc-receptor-independent way Blood, May 15, 2007; 109(10): 4376 - 4382. [Abstract] [Full Text] [PDF]

				G. Steup-Beekman, S. Steens, M. van Buchem, and T. Huizinga Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives Lupus, May 1, 2007; 16(5): 329 - 334. [Abstract] [PDF]

				J. J. Alexander, A. Jacob, L. Bao, R. L. Macdonald, and R. J. Quigg Complement-Dependent Apoptosis and Inflammatory Gene Changes in Murine Lupus Cerebritis J. Immunol., December 15, 2005; 175(12): 8312 - 8319. [Abstract] [Full Text] [PDF]